Related Experiment Video
Updated: Feb 15, 2026

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis
Published on: August 1, 2019
Metformin and oncogenic pathways: Crosstalk between energy sensing and tumor progression
Ying Zhang1, Long Zhao1, Kai Zhang1
1Department of Pharmacy, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, 157000, China.
Abstract:
Metformin, a widely prescribed oral biguanide for type 2 diabetes mellitus, has gained significant attention as a potential anti-cancer agent. Beyond its established role in improving insulin sensitivity and lowering blood glucose, preclinical and epidemiological studies suggest that metformin exerts anti-tumor effects through both insulin-dependent and insulin-independent mechanisms. Central to its activity is the activation of AMP-activated protein kinase (AMPK), which disrupts the mammalian target of rapamycin (mTOR) pathway, leading to cell cycle arrest, apoptosis, and reduced tumor growth. Additionally, metformin modulates oncogenic signaling networks such as PI3K/Akt, Erk, and receptor tyrosine kinases, while influencing tumor metabolism, angiogenesis, and immune responses. By inhibiting mitochondrial complex I, metformin interferes with cancer cell bioenergetics and the Warburg effect, further contributing to its anti-cancer potential. Clinical studies, however, have yielded mixed results, underscoring the complexity of metformin's effects and the need for rigorous investigation. This review highlights the multifaceted mechanisms by which metformin impacts tumor progression and discusses its promise and challenges as a therapeutic agent in cancer prevention and treatment.
Insights
Metformin, a diabetes drug, shows potential as an anti-cancer agent by activating AMP-activated protein kinase (AMPK) to inhibit tumor growth. Further research is needed to clarify its complex effects in cancer prevention and treatment.
Area of Science:
- Oncology
- Pharmacology
- Metabolic Diseases
Background:
- Metformin is a first-line oral biguanide medication for type 2 diabetes mellitus.
- Preclinical and epidemiological data suggest metformin possesses anti-cancer properties.
- Its anti-tumor effects are mediated through both insulin-dependent and insulin-independent pathways.
Purpose of the Study:
- To review the multifaceted mechanisms of metformin's anti-cancer activity.
- To discuss the potential of metformin in cancer prevention and treatment.
- To highlight the challenges and complexities observed in clinical studies.
Main Methods:
- Review of preclinical studies on metformin's anti-tumor effects.
- Analysis of epidemiological data linking metformin use to cancer outcomes.
- Examination of clinical trial results regarding metformin's efficacy in cancer.
- Focus on molecular mechanisms including AMPK activation and mTOR inhibition.
Main Results:
- Metformin activates AMP-activated protein kinase (AMPK), inhibiting the mTOR pathway, leading to cell cycle arrest and apoptosis.
- It modulates key oncogenic signaling pathways (PI3K/Akt, Erk) and influences tumor metabolism, angiogenesis, and immunity.
- Inhibition of mitochondrial complex I by metformin disrupts cancer cell bioenergetics and the Warburg effect.
- Clinical studies present mixed results, indicating a complex therapeutic profile.
Conclusions:
- Metformin exhibits diverse anti-cancer mechanisms, impacting tumor growth, metabolism, and signaling.
- While promising, its clinical application in cancer therapy requires further rigorous investigation due to complex and sometimes conflicting results.
- Metformin's potential in cancer prevention and treatment warrants continued research to optimize its use.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Sense of Self: Reflected Self-Appraisal and Social Comparison
What is Energy?
Free Energy
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Energy Basics

